Keyphrases
5-fluorouracil (5-FU)
21%
Cancer Care
16%
Cancer Care Coordination
15%
Cancer Patients
17%
Care Coordination
29%
Catenin
24%
Chediak-Higashi Syndrome
32%
Chemotherapy
19%
Clinical Research
14%
Clinical Trials
21%
Colon
16%
Colon Adenocarcinoma
12%
Colon Cancer
37%
Colonic mucosa
10%
Gemcitabine
16%
Genistein
11%
Hawaii
15%
Health Systems
18%
Healthcare Professionals
15%
In Cancer
22%
Inflammatory Bowel Disease
13%
Interferon-α (IFN-α)
11%
Interleukin-2
11%
LAMP2
20%
LEF1
16%
Levamisole
31%
Lipids
11%
Metastatic Colorectal Cancer (mCRC)
20%
New York City
14%
Oncohematology
15%
Oncologists
12%
Patient Perception
11%
Patient Satisfaction
17%
Peripheral Blood Mononuclear Cells
22%
Resveratrol
16%
Rural Patients
10%
Signaling Pathway
15%
Southwest Oncology Group
13%
Surface Expression
10%
T Cell Receptor
13%
T Cells
16%
Tumor
15%
Tumor Microenvironment
15%
United States
11%
Wnt Antagonists
16%
Wnt Genes
11%
Wnt Ligands
21%
Wnt Signaling
43%
Wnt Signaling Pathway
40%
Wnt2
11%
Medicine and Dentistry
Anticarcinogen
6%
Breast Cancer
16%
Cancer
10%
Cancer Prevention
8%
Cancer Therapy
18%
Carcinogenesis
13%
Care Coordination
33%
Catenin
7%
Cell Invasion
9%
Chediak Higashi Syndrome
8%
Chemotherapy
25%
Cholangiocarcinoma
13%
Clinical Research
18%
Clinical Trial
26%
Clinician
7%
Colon Carcinoma
27%
Colon Mucosa
7%
Disease
18%
Drug Therapy
7%
Frizzled Protein
11%
Gastroesophageal Junction
6%
Gemcitabine
12%
Granulocyte
11%
Health Care Cost
8%
Hematology
19%
Immunity
8%
In Vitro
10%
Inflammatory Bowel Disease
9%
Interleukin 2
6%
Levamisole
13%
Low Drug Dose
8%
Lymphocyte
7%
Lymphoid Enhancer Factor 1
9%
Malignant Neoplasm
100%
Mammography
9%
Metastatic Carcinoma
8%
Neoplasm
18%
Oncologist
11%
Oncology
49%
Overall Survival
9%
Pancreas Cancer
9%
Patient Satisfaction
9%
Peripheral Blood Mononuclear Cell
8%
Platelet
6%
Prescription Medication
6%
Radiation Therapy
8%
Receptor
8%
Signal Transduction
7%
Tumor Microenvironment
10%
Wnt Signaling
40%